{"id":2450,"date":"2023-04-24T00:00:00","date_gmt":"2023-04-24T05:00:00","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/blog\/national-prescription-drug-take-back-day\/"},"modified":"2023-04-24T00:00:00","modified_gmt":"2023-04-24T05:00:00","slug":"national-prescription-drug-take-back-day","status":"publish","type":"blog","link":"https:\/\/www.mdbriefcase.com\/fr\/blog\/national-prescription-drug-take-back-day\/","title":{"rendered":"National Prescription Drug Take Back Day"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Opioid misuse is a public health crisis in many countries, which has led to a high rate of overdose deaths and addiction. During the COVID-19 pandemic, deaths from accidental overdose increased in Canada\u00a0<\/span><a href=\"https:\/\/www.ccsa.ca\/sites\/default\/files\/2022-11\/CCSA-Canadian-Drug-Summary--Opioids-2022-en.pdf\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">by 91 percent<\/span><\/a><span style=\"font-weight: 400;\"> from April 2020 to March 2022.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">National prescription drug return programs can reduce and prevent opioid misuse and addiction. Healthcare providers also play a critical role in prevention and effective pain management practices.\u00a0<\/span><\/p>\n<h2><b>Understanding the Opioid Epidemic\u00a0<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Since surveillance began in 2016, the rates of opioid addiction and\u00a0<\/span><a href=\"https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">related deaths<\/span><\/a><span style=\"font-weight: 400;\"> in Canada have steadily increased. There are a few key factors.\u00a0<\/span><\/p>\n<h3><b>Causes of Misuse<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Opioid medications are important for acute and palliative pain management and sometimes chronic pain. However, these medications have a high potential for misuse because they produce euphoria and are addictive. Certain factors increase the risk.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Overprescribing is a chief\u00a0factor <\/span><a href=\"https:\/\/www.cmpa-acpm.ca\/static-assets\/pdf\/about\/annual-meeting\/com_16_opioid_We_can_do_better-e.pdf\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">in misuse<\/span><\/a><span style=\"font-weight: 400;\"> and includes high doses and long-term prescribing.\u00a0Once patients develop a physical dependence, they may also engage in double doctoring.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These patients switch between doctors, nurses, and pharmacists to get multiple prescriptions or until they find one willing to prescribe opioids. This leads to overprescribing, especially in areas without drug monitoring systems, and to prescription fraud.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Untreated or poorly managed mental illness is also a factor. Patients may seek out opioids or turn to illicit drugs for euphoria, to improve mood, or to cope with stress.\u00a0<\/span><\/p>\n<h2><b>Best Practices for Opioid Misuse Prescribing\u00a0<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">As a healthcare provider, you play a critical role in misuse prevention. One of the most important elements is appropriate prescribing practices, from managing pain with other methods to trial dosing and close patient monitoring.\u00a0<\/span><\/p>\n<h3><b>Current Guidelines<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Opioid\u00a0<\/span><a href=\"https:\/\/www.cfpc.ca\/CFPC\/media\/Resources\/Pain-Management\/Opioid-poster_CFP_ENG.pdf\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">prescribing guidelines<\/span><\/a><span style=\"font-weight: 400;\"> went into effect in Canada in 2017 and outline the best approach to prescribing opioids and at what doses.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These guidelines apply to non-cancer, chronic pain:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Manage pain with non-opioid medications or non-drug therapies first.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Trial opioids only after you\u2019ve exhausted other methods.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not prescribe to patients with a history of a substance use disorder.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not prescribe to patients with mental illness until stabilized.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Restrict dosage to under 90 mg morphine equivalents daily (MED) for patients starting opioids, though under 50 mg MED is highly recommended.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Encourage patients already taking more than 90 mg MED to start gradual tapering.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Give clear instructions for medication use and refill policies.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Monitor patients closely and adjust as necessary.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Get informed consent before starting patients on opioids.\u00a0<\/span><\/li>\n<\/ul>\n<h3><b>Patient Risk Assessment and Monitoring<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Patient\u00a0<\/span><a href=\"https:\/\/cep.health\/media\/uploaded\/CEP_Opioid_Manager_2017.pdf\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">risk assessment<\/span><\/a><span style=\"font-weight: 400;\"> and monitoring are a constant part of prescribing opioids. Screen for risk factors before starting a patient on a prescription, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">History of substance misuse, including alcohol<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Current substance use disorder<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mental illness<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cannabis use<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Once the patient starts the medication, monitor for signs of misuse, adverse reactions, pain intensity, and changes in functional status. For best results, identify the lowest effective dose. Opioids lose effectiveness for pain relief after three to six months due to tolerance.\u00a0<\/span><\/p>\n<h3><b>Use PDMP for Diversion Prevention<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Electronic databases in a prescription drug monitoring program (PDMP) help pharmacists and clinicians monitor prescriptions and opioid use.\u00a0<\/span><a href=\"https:\/\/www.mdbriefcase.com\/fr\/course\/e-prescribing-completing-the-virtual-healthcare-suite\/?courseid=591\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">E-prescriptions<\/span><\/a><span style=\"font-weight: 400;\"> sent directly to pharmacists can prevent fraud and increase patient safety.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pharmacists must complete an assessment and log it every time a patient fills a new opioid prescription or refills one. These checks and balances reveal red flags about patient misuse.\u00a0<\/span><\/p>\n<h2><b>Alternative Pain Management Strategies\u00a0<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Other pain-relief strategies can improve quality of life. A combination of therapies might be helpful, but consider patient income and insurance coverage. Those with low-income status may not have access to some treatments, so this strategy can backfire and encourage them to look for illicit drugs.\u00a0<\/span><\/p>\n<h3><b>Non-opioid Medications<\/b><\/h3>\n<p><a href=\"https:\/\/cep.health\/media\/uploaded\/CEP_Opioid_Manager_2017.pdf\" target=\"_blank\" rel=\"nofllow noopener\"><span style=\"font-weight: 400;\">Non-opioid treatments<\/span><\/a><span style=\"font-weight: 400;\"> are the first line of treatment for non-cancer chronic pain. These include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Non-steroidal anti-inflammatory drugs (NSAIDs)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Acetaminophen<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Anticonvulsants<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Antidepressants<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Topical analgesics like capsaicin<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Non-medication therapies may also relieve pain, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Low-level laser therapy<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Massage therapy<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Manual therapy<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Transcutaneous electrical nerve stimulation (TENS)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Exercise and strength training<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Yoga\u00a0<\/span><\/li>\n<\/ul>\n<h3><b>Behavioural Therapies<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Behavioural therapies can help patients learn how to\u00a0<\/span><a href=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/international-pain-awareness-month-spotlight-on-chronic-pain-management\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">cope with pain<\/span><\/a><span style=\"font-weight: 400;\"> and reframe thoughts about pain. These therapies can also help patients set goals to add activity at a sustainable pace.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Behavioural therapies can include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mindfulness training<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cognitive behavioural therapy<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Acceptance and commitment therapy<\/span><\/li>\n<\/ul>\n<h2><b>Addressing Opioid Addiction and Misuse<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Encourage patients with high doses and long-term use to taper medications. If they experience adverse effects, switching opioids can be one way to encourage tapering. Follow up every three days during a switch and weekly during tapering. Referral to rehabilitative services may be necessary.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Awareness of causes, guidelines, and strategies is essential in clinical practice to reduce and prevent opioid misuse and addiction. Join the\u00a0<\/span><a href=\"https:\/\/www.mdbriefcase.com\/fr\/user-account\/?action=eb_register\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">MDBriefCase community<\/span><\/a><span style=\"font-weight: 400;\"> for free and stay up-to-date.\u00a0<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Opioid misuse is a public health crisis in many countries, which has led to a high rate of overdose deaths and addiction. During the COVID-19 pandemic, deaths from accidental overdose increased in Canada\u00a0by 91 percent from April 2020 to March 2022.\u00a0 National prescription drug return programs can reduce and prevent opioid misuse and addiction. Healthcare [&hellip;]<\/p>\n","protected":false},"featured_media":2451,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"categories":[64],"class_list":["post-2450","blog","type-blog","status-publish","has-post-thumbnail","hentry","category-deep-understandingfurther-educationlearning-and-development"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>National Prescription Drug Take Back Day - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/national-prescription-drug-take-back-day\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"National Prescription Drug Take Back Day - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Opioid misuse is a public health crisis in many countries, which has led to a high rate of overdose deaths and addiction. During the COVID-19 pandemic, deaths from accidental overdose increased in Canada\u00a0by 91 percent from April 2020 to March 2022.\u00a0 National prescription drug return programs can reduce and prevent opioid misuse and addiction. Healthcare [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/national-prescription-drug-take-back-day\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/National-Prescription-Drug-Take-Back-Day.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/\",\"name\":\"National Prescription Drug Take Back Day - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/National-Prescription-Drug-Take-Back-Day.jpg\",\"datePublished\":\"2023-04-24T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/National-Prescription-Drug-Take-Back-Day.jpg\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/National-Prescription-Drug-Take-Back-Day.jpg\",\"width\":1080,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/blog\\\/national-prescription-drug-take-back-day\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"National Prescription Drug Take Back Day\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mdbriefcase.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"National Prescription Drug Take Back Day - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/blog\/national-prescription-drug-take-back-day\/","og_locale":"fr_CA","og_type":"article","og_title":"National Prescription Drug Take Back Day - MDBriefCase","og_description":"Opioid misuse is a public health crisis in many countries, which has led to a high rate of overdose deaths and addiction. During the COVID-19 pandemic, deaths from accidental overdose increased in Canada\u00a0by 91 percent from April 2020 to March 2022.\u00a0 National prescription drug return programs can reduce and prevent opioid misuse and addiction. Healthcare [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/blog\/national-prescription-drug-take-back-day\/","og_site_name":"MDBriefCase","og_image":[{"width":1080,"height":720,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/National-Prescription-Drug-Take-Back-Day.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/","url":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/","name":"National Prescription Drug Take Back Day - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/National-Prescription-Drug-Take-Back-Day.jpg","datePublished":"2023-04-24T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/National-Prescription-Drug-Take-Back-Day.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/National-Prescription-Drug-Take-Back-Day.jpg","width":1080,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/blog\/national-prescription-drug-take-back-day\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"National Prescription Drug Take Back Day"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/blog\/2450","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/blog"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/2451"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=2450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/categories?post=2450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}